Mumuni Sumaila, Pradeep Kumar, Philemon Ubanako, Samson A. Adeyemi & Yahya E. Choonara. (2023) Dual Rifampicin and Isoniazid Mannose-Decorated Lipopolysaccharide Nanospheres for Macrophage-
Targeted Lung Delivery. Current Drug Delivery 20:10, pages 1487-1503.
Crossref
Mitali Patel, Sneha Karampuri, Vrushti Kansara & Bhavin Vyas. (2023) Inhalable dry powder containing lipid polymer hybrid nanoparticles of Nintedanib esylate: In vitro and in vivo evaluations. Journal of Drug Delivery Science and Technology, pages 104716.
Crossref
Sara Ahmed, Mai Mansour, Rania A.H. Ishak & Nahed D. Mortada. (2023) Customizable resveratrol spray-dried micro-composites for inhalation as a promising contender for treatment of idiopathic pulmonary fibrosis. International Journal of Pharmaceutics 642, pages 123117.
Crossref
Prakash Khadka, Jack Dummer, Philip C. Hill, Rajesh Katare & Shyamal C. Das. (2022) A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation. Drug Delivery and Translational Research 13:5, pages 1246-1271.
Crossref
Riya Mahar, Arpita Chakraborty, Nidhi Nainwal, Richa Bahuguna, Meenakshi Sajwan & Vikash Jakhmola. (2023) Application of PLGA as a Biodegradable and Biocompatible Polymer for Pulmonary Delivery of Drugs. AAPS PharmSciTech 24:1.
Crossref
Piyush Pradeep Mehta & Prakash Dilip Jadhav. 2023. Green Sustainable Process for Chemical and Environmental Engineering and Science. Green Sustainable Process for Chemical and Environmental Engineering and Science
131
186
.
Simisola Ayodele, Pradeep Kumar, Armorel van Eyk & Yahya E. Choonara. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems
261
287
.
Eman Elhassan, Nikita Devnarain, Mahir Mohammed, Thirumala Govender & Calvin A. Omolo. (2022) Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections. Journal of Controlled Release 351, pages 598-622.
Crossref
Ritu Rathi, Manju Nagpal, Malkiet Kaur, Priyansh Ballouria, Redhima Dutta, Geeta Aggarwal & Sandeep Arora. (2022) Treatment of Tuberculosis in Nano Era: Recent Avenues. Current Bioactive Compounds 18:7.
Crossref
Nidhi Nainwal, Yuwanshi Sharma & Vikash Jakhmola. (2022) Dry powder inhalers of antitubercular drugs. Tuberculosis 135, pages 102228.
Crossref
Priyanka Maurya, Ravi Saklani, Samipta Singh, Raquibun Nisha, Ravi Raj Pal, Nidhi Mishra, Priya Singh, Abhiram Kumar, Manish K. Chourasia & Shubhini A. Saraf. (2021) Appraisal of fluoroquinolone-loaded carubinose-linked hybrid nanoparticles for glycotargeting to alveolar macrophages. Drug Delivery and Translational Research 12:7, pages 1640-1658.
Crossref
Estefanía Fernández-Paz, Cristina Fernández-Paz, Sheila Barrios-Esteban, Irene Santalices, Noemi Csaba & Carmen Remuñán-López. (2022) Dry powders containing chitosan-based nanocapsules for pulmonary administration: Adjustment of spray-drying process and in vitro evaluation in A549 cells. Powder Technology 399, pages 117149.
Crossref
Kaushik Sarkar, Manish Kumar, Abhishek Jha, Kanchan Bharti, Mohana Das & Brahmeshwar Mishra. (2022) Nanocarriers for tuberculosis therapy: Design of safe and effective drug delivery strategies to overcome the therapeutic challenges. Journal of Drug Delivery Science and Technology 67, pages 102850.
Crossref
Amarjitsing Rajput, Satish Mandlik & Varsha Pokharkar. (2021) Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis. Frontiers in Pharmacology 12.
Crossref
Sheersha Pramanik, Sourav Mohanto, Ravi Manne, Rahul R. Rajendran, A. Deepak, Sijo Joy Edapully, Triveni Patil & Oly Katari. (2021) Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases. Molecular Pharmaceutics 18:10, pages 3671-3718.
Crossref
Goutam Rath, Deepak Pradhan, Goutam Ghosh & Amit K. Goyal. (2021) Challenges and Opportunities of Nanotechnological based Approach for the Treatment of Tuberculosis. Current Pharmaceutical Design 27:17, pages 2026-2040.
Crossref
Sabrina Bochicchio, Gaetano Lamberti & Anna Angela Barba. (2021) Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies. Pharmaceutics 13:2, pages 198.
Crossref
Priya Shrivastava, Laxmikant Gautam, Anamika Jain, Nikhar Vishwakarma, Sonal Vyas & Suresh P. Vyas. 2021. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer
87
113
.
Zhi Ming Tan, Gui Ping Lai, Manisha Pandey, Teerapol Srichana, Mallikarjuna Rao Pichika, Bapi Gorain, Subrat Kumar Bhattamishra & Hira Choudhury. (2020) Novel Approaches for the Treatment of Pulmonary Tuberculosis. Pharmaceutics 12:12, pages 1196.
Crossref
Priyanka Maurya, Samipta Singh & Shubhini A. Saraf. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
281
302
.
Mohsen Tafaghodi, Farzad Khademi, Farideh shiehzadeh & Zohreh Firouzi. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
123
142
.
Damián Eduardo Pérez-Martínez & Roberto Zenteno-Cuevas. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
37
52
.
Josef Jampílek & Katarína Kráľová. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
469
502
.
Nazimuddin Chishti, Satveer Jagwani, Dinesh Dhamecha, Sunil Jalalpure & Mohamed Hassan Dehghan. (2019) Preparation, Optimization, and In Vivo Evaluation of Nanoparticle-Based Formulation for Pulmonary Delivery of Anticancer Drug. Medicina 55:6, pages 294.
Crossref
Chunxia Liu, Ling Lin, Zhengwei Huang, Qiaoli Wu, Junhuang Jiang, Li Lv, Xiaoxia Yu, Guilan Quan, Guocheng Li & Chuanbin Wu. (2019) Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol–Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties. AAPS PharmSciTech 20:2.
Crossref
Shahinda S.R. Alsayed, Chau C. Beh, Neil R. Foster, Alan D. Payne, Yu Yu & Hendra Gunosewoyo. (2019) Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis. Current Molecular Pharmacology 12:1, pages 27-49.
Crossref
Hongli Yu, Yonghong Wang, Saisai Wang, Xujing Li, Wentong Li, Dejun Ding, Xiaoming Gong, Michael Keidar & Weifen Zhang. (2018) Paclitaxel-Loaded Core–Shell Magnetic Nanoparticles and Cold Atmospheric Plasma Inhibit Non-Small Cell Lung Cancer Growth. ACS Applied Materials & Interfaces 10:50, pages 43462-43471.
Crossref
Estefania Grotz, Nancy Tateosian, Nicolas Amiano, Maximiliano Cagel, Ezequiel Bernabeu, Diego A. Chiappetta & Marcela A. Moretton. (2018) Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead. Pharmaceutical Research 35:11.
Crossref
Oluwatoyin A. Adeleke, Pei-Chin Tsai, Krizia M. Karry, Nkwe O. Monama & Bozena B. Michniak-Kohn. (2018) Isoniazid-loaded orodispersible strips: Methodical design, optimization and in vitro-in silico characterization. International Journal of Pharmaceutics 547:1-2, pages 347-359.
Crossref
Rui Xue Zhang, Taksim Ahmed, Lily Yi Li, Jason Li, Azhar Z. Abbasi & Xiao Yu Wu. (2017) Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks. Nanoscale 9:4, pages 1334-1355.
Crossref